Similar authors to follow
Manage your follows
About Hinrich Göhlmann
Hinrich W.H. Gohlmann is a Senior Principal Scientist at Janssen Research & Development. He has studied Biology at the Technische Hochschule Darmstadt (Germany) and received his doctoral degree from the University of Heidelberg (Germany). He is currently leading the High Dimensional Biology team at Johnson & Johnson's research site in Beerse, Belgium. The team is using various 'omics technologies (Next Generation Sequencing using 454/Roche and Illumina, Affymetrix GeneChip and GeneTitan systems, RNAi platform, FACS and High Content Screening) to assist research in various disease areas.
For more information, please visit: http://goehlmann.info
Its broad scope brings together critical knowledge from many disciplines, ranging from process technology to pharmacology to intellectual property issues.
After introducing the overall early development workflow, the critical steps of early drug development are described in a sequential and enabling order: the availability of the drug substance and that of the drug product, the prediction of pharmacokinetics and -dynamics, as well as that of drug safety. The final section focuses on intellectual property aspects during early clinical development. The emphasis throughout is on recent case studies to exemplify salient points, resulting in an abundance of practice-oriented information that is usually not available from other sources.
Aimed at medicinal chemists in industry as well as academia, this invaluable reference enables readers to understand and navigate the challenges in developing clinical candidate molecules that can be successfully used in phase one clinical trials.
Proven Methods for Big Data Analysis
As big data has become standard in many application areas, challenges have arisen related to methodology and software development, including how to discover meaningful patterns in the vast amounts of data. Addressing these problems, Applied Biclustering Methods for Big and High-Dimensional Data Using R shows how to apply biclustering methods to find local patterns in a big data matrix.
The book presents an overview of data analysis using biclustering methods from a practical point of view. Real case studies in drug discovery, genetics, marketing research, biology, toxicity, and sports illustrate the use of several biclustering methods. References to technical details of the methods are provided for readers who wish to investigate the full theoretical background. All the methods are accompanied with R examples that show how to conduct the analyses. The examples, software, and other materials are available on a supplementary website.
This book focuses on the analysis of dose-response microarray data in pharmaceutical settings, the goal being to cover this important topic for early drug development experiments and to provide user-friendly R packages that can be used to analyze this data. It is intended for biostatisticians and bioinformaticians in the pharmaceutical industry, biologists, and biostatistics/bioinformatics graduate students.
Part I of the book is an introduction, in which we discuss the dose-response setting and the problem of estimating normal means under order restrictions. In particular, we discuss the pooled-adjacent-violator (PAV) algorithm and isotonic regression, as well as inference under order restrictions and non-linear parametric models, which are used in the second part of the book.
Part II is the core of the book, in which we focus on the analysis of dose-response microarray data. Methodological topics discussed include:
• Multiplicity adjustment
• Test statistics and procedures for the analysis of dose-response microarray data
• Resampling-based inference and use of the SAM method for small-variance genes in the data
• Identification and classification of dose-response curve shapes
• Clustering of order-restricted (but not necessarily monotone) dose-response profiles
• Gene set analysis to facilitate the interpretation of microarray results
• Hierarchical Bayesian models and Bayesian variable selection
• Non-linear models for dose-response microarray data
• Multiple contrast tests
• Multiple confidence intervals for selected parameters adjusted for the false coverage-statement rate
All methodological issues in the book are illustrated using real-world examples of dose-response microarray datasets from early drug development experiments.